Download PDF
Synlett 2007(17): 2759-2761  
DOI: 10.1055/s-2007-986659
LETTER
© Georg Thieme Verlag Stuttgart · New York

Solution-Phase Parallel Synthesis of Dissymmetric Disubstituted Malonamides Carrying Amino Ester Residues

Stefania Fioravanti*, Alberto Morreale, Lucio Pellacani*, Federico Ramadori, Paolo A. Tardella*
Dipartimento di Chimica, Università degli Studi di Roma ‘La Sapienza’, P.le Aldo Moro 2, 00185 Rome, Italy
Fax: +39(06)490631; e-Mail: lucio.pellacani@uniroma1.it;
Further Information

Publication History

Received 27 June 2007
Publication Date:
12 September 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

Amino esters were used as nucleophiles in the reaction with Meldrum’s acid to obtain monosubstituted malonic acids that reacted under coupling reaction conditions with a second different amino ester residue to give single >COCH2CO< retropeptide units in high overall yields. The synthetic procedure led to the construction of a 4 × 5 combinatorial library of malonyl peptides.

Key words

amino acids - combinatorial chemistry - Meldrum’s ­acid - amides - retropeptides

    References and Notes

  • 1a Chorev M. Biopolymers  2005,  80:  67 
    CrossrefGoogle Scholar
  • 1b Fletcher MD. Campbell MM. Chem. Rev.  1998,  98:  763 
    CrossrefGoogle Scholar
  • 1c Zhao M. Kleinman HK. Mokotoff M. J. Pept. Res.  1997,  49:  240 
    CrossrefGoogle Scholar
  • 1d Chorev M. Goodman M. Trends Biotechnol.  1995,  13:  438 
    CrossrefGoogle Scholar
  • 1e Chorev M. Goodman M. Acc. Chem. Res.  1993,  26:  266 
    CrossrefGoogle Scholar
  • 2a Davis SS. In Perspectives in Medicinal Chemistry   Testa B. Kyburz E. Fuhrer W. Giger R. Verlag Helvetica Chimica Acta; Basel: 1993.  p.533 
    CrossrefGoogle Scholar
  • 2b Giannis A. Kolter T. Angew. Chem., Int. Ed. Engl.  1993,  32:  1244 
    CrossrefGoogle Scholar
  • 3a Biron Z. Khare S. Quadt SR. Hayek Y. Naider F. Anglister J. Biochemistry  2005,  44:  13602 
    CrossrefGoogle Scholar
  • 3b Schneider SE. Bray BL. Mader CJ. Friedrich PE. Anderson MW. Taylor TS. Boshernitzan N. Niemi TE. Fulcher BC. Whight SR. White JM. Greene RJ. Stoltenberg LE. Lichty M. J. Pept. Sci.  2005,  11:  744 
    CrossrefGoogle Scholar
  • 3c Veiga AS. Santos NC. Loura LMS. Fedorov A. Castanho MARB. J. Am. Chem. Soc.  2004,  126:  14758 
    CrossrefGoogle Scholar
  • 3d Wiley RA. Rich DH. Med. Res. Rev.  1993,  13:  327 
    CrossrefGoogle Scholar
  • 4a Gante J. Angew. Chem., Int. Ed. Engl.  1994,  33:  1699 
    Google Scholar
  • 4b Grant SK. Meek TD. Metcalf BW. Petteway SR. Biomed. Appl. Biotechnol.  1993,  1:  325 
    Google Scholar
  • 5a Trabocchi A. Menchi G. Guarna F. Machetti F. Scarpi D. Guarna A. Synlett  2006,  331 
    CrossrefGoogle Scholar
  • 5b Nefzi A. Ostresh JM. Yu J. Houghten RA. J. Org. Chem.  2004,  69:  3603 
    CrossrefGoogle Scholar
  • 5c Liu R. Marik J. Lam KS. Methods Enzymol.  2003,  369:  271 
    CrossrefGoogle Scholar
  • 5d Lam KS. Lehman AL. Song A. Doan N. Enstrom AM. Maxwell J. Liu R. Methods Enzymol.  2003,  369:  298 
    CrossrefGoogle Scholar
  • 5e Szostak JW. Chem. Rev.  1997,  97:  347 
    CrossrefGoogle Scholar
  • 6a Gibert L. Gonzalez A. Granell J. Lopez C. Tetrahedron: Asymmetry  2002,  13:  983 
    Google Scholar
  • 6b Fujii H. Nishikawa N. Komazawa H. Suzuki M. Kojima M. Itoh I. Obata A. Ayukawa K. Azuma I. Saiki I. Clin. Exp. Metastasis  1998,  16:  94 
    Google Scholar
  • 6c Fujii H. Nishikawa N. Komazawa H. Orikasa A. Ono M. Itoh I. Murata J. Azuma I. Saiki I. Oncol. Res.  1996,  8:  333 
    Google Scholar
  • 7 Pallai PV. Richman S. Struthers RS. Goodman M. Int. J. Pept. Protein Res.  1983,  21:  84 
    Google Scholar
  • 8a Nishikawa N. Komazawa H. Orikasa A. Yoshikane M. Yamaguchi J. Kojima M. Ono M. Itoh I. Azuma I. Fujii H. Murata J. Saiki I. Bioorg. Med. Chem. Lett.  1996,  6:  2725 
    CrossrefGoogle Scholar
  • 8b Dalpozzo A. Kanai K. Kereszturi G. Calabrese G. Int. J. Pept. Protein Res.  1993,  41:  561 
    CrossrefGoogle Scholar
  • 8c Verdini AS. Silvestri S. Becherucci C. Longobardi MG. Parente L. Peppoloni S. Perretti M. Pileri P. Pinori M. Viscomi GC. Nencioni L. J. Med. Chem.  1991,  34:  3372 
    CrossrefGoogle Scholar
  • 9a Kudo H. Sanda F. Endo T. Tetrahedron Lett.  2001,  42:  7847 
    Google Scholar
  • 9b Phanstiel OIV. Lachicotte RJ. Torres D. Richardson M. Matsui H. Schaffer H. Adar F. Liu J. Seconi D. Chem. Mater.  2001,  13:  264 
    Google Scholar
  • 9c Jain D. Tripathi M. Kohli DV. Uppadhyay RK. Arch. Pharmacol. Res  1992,  15:  184 
    Google Scholar
  • 10 IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), Eur. J. Biochem.  1984,  138:  9 
    CrossrefGoogle Scholar
  • 11 Gaber AE.-AM. McNab H. Synthesis  2001,  2059 
    Article in Thieme ConnectGoogle Scholar
  • 12 Rigo B. Fasseur D. Cauliez P. Couturier D. Tetrahedron Lett.  1989,  30:  3073 
    CrossrefGoogle Scholar
  • 18 Ceretti S. Luppi G. De Pol S. Formaggio F. Crisma M. Toniolo C. Tomasini C. Eur. J. Org. Chem.  2004,  4188 
    CrossrefGoogle Scholar
13

The molar ratios of Meldrum’s acid to amino ester were a crucial point in order to avoid the undesired formation of a symmetric disubstituted malonamide.

14

By refluxing in toluene only the N-acetyl amino ester was obtained as a consequence of the decarboxylation reaction.

15

The reaction was monitored by IR and MS-Q-TOF every 30 min until completion.

16

Typical Experimental Procedure
Equimolar amounts (from 250 mg up to multigram scale) of a suitable amino ester hydrochloride and Et3N were stirred in THF (3 mL/mmol) at r.t. After 30 min, a twofold excess of Meldrum’s acid was added, and then the reaction mixture was allowed to reflux for 3 h. After filtration and solvent removal, the malonic acid monoamides were obtained as crude products and used as such. The crude malonic acid monoamides were dissolved in CH2Cl2 and equimolar amounts of a suitable amino ester hydrochloride and DMAP were added. After stirring for 15 min, an equimolar amount of DCC was added and the mixture was stirred for additional 12 h. After reaction completion, the crude mixture was filtered and the expected malonyl peptides were collected as pure compounds after chromatography on silica gel (eluent mixture: hexane-EtOAc = 5:95).

17

Representative Spectral Data for 3A{1-4}B1
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)-3-phenylpropanoate (3A1B1)
Viscous oil. IR: 3442, 3328, 1739, 1679 cm-1. 1H NMR (300 MHz, CDCl3): δ = 2.92-3.18 (m, 2 H), 3.19 (s, 2 H), 3.64 (s, 3 H), 3.68 (s, 3 H), 3.96 (d, J = 5.4 Hz, 2 H), 4.71-4.82 (m, 1 H), 7.05-7.26 (m, 5 H), 7.62-7.76 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 37.6, 41.0, 42.1, 52.1 (two), 53.5, 126.8, 128.3, 129.0, 135.8, 167.0, 167.3, 169.8, 171.5. HRMS (ES Q-TOF): m/z calcd for C16H21N2O6 [M + H]+: 337.1394; found: 337.1387
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)propanoate (3A2B1)
Viscous oil. IR: 3424, 3326, 1744, 1678 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.36 (d, J = 7.2 Hz, 3 H), 3.28 (s, 2 H), 3.68 (s, 3 H), 3.69 (s, 3 H), 3.94-4.01 (m, 2 H), 4.42-4.56 (m, 1 H), 7.73 (d, J = 6.9 Hz, 1 H), 7.77-7.83 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 17.6, 41.1, 42.1, 52.2 (two), 52.3, 166.9, 167.6, 169.9, 173.0. HRMS (ES Q-TOF): m/z calcd for C10H17N2O6 [M + H]+: 261.1081; found: 261.1079 Methyl 3-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)propanoate (3A3B1)
Viscous oil. IR: 3445, 3327, 1737, 1679 cm-1. 1H NMR (300 MHz, CDCl3): δ = 2.42-2.48 (m, 2 H), 3.17 (s, 2 H), 3.37-3.44 (m, 2 H), 3.58 (s, 3 H), 3.63 (s, 3 H), 3.92 (d, J = 5.4 Hz, 2 H), 7.60-7.65 (m, 1 H), 7.92-7.94 (m, 1 H).13C NMR (75 MHz, CDCl3): δ = 33.4, 34.8, 41.0, 42.2, 51.5, 51.9, 167.2, 167.7, 169.9, 172.2. HRMS (ES Q-TOF): m/z calcd for C10H17N2O6 [M + H]+: 261.1081; found: 261.1090
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)-3-methylbutanoate (3A4B1)
Viscous oil. IR: 3425, 3326, 1742, 1679 cm-1. 1H NMR (300 MHz, CDCl3): δ = 0.88 (d, J = 6.6 Hz, 3 H), 0.90 (d, J = 6.6 Hz, 3 H), 2.10-2.20 (m, 1 H), 3.31 (s, 2 H), 3.70 (s, 3 H), 3.71 (s, 3 H), 4.00 (d, J = 5.4 Hz, 2 H), 4.41-4.48 (m, 1 H), 7.72 (d, J = 7.8 Hz, 1 H), 7.79 (d, J = 7.8 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ = 17.7, 18.9, 30.8, 41.0, 42.0, 52.0, 52.2, 57.5, 167.2, 167.7, 169.9, 172.2. HRMS (ES Q-TOF): m/z calcd for C12H21N2O6 [M + H]+: 289.1394; found: 289.1401.